BioMarin Pharmaceutical Inc.BMRN
NasdaqGS•Healthcare•Biotechnology
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $3.24B, growing 9.9% year-over-year. TTM net income stood at $268.74M (48.7% contraction). Quarterly EBITDA was $146.05M and operating income was $129.64M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze BMRN growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters